Lv1
48 积分 2024-02-29 加入
Updated Overall Survival Analysis From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
11天前
已关闭
The efficacy and safety of cadonilimab after first anti-PD-1 failure in the treatment of recurrent endometrial and cervical carcinoma: A retrospective, real-world study
19天前
已完结
Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: Pooled analysis of TRYPHAENA and NeoSphere trials
1个月前
已完结
Modified Diamond-Shaped Umbilicoplasty in Abdominoplasty
1个月前
已完结
Comparison of Aesthetic Results of Mercedes-Y Versus Inverted-V Incision for Umbilical Reconstruction: A Randomized Clinical Trial
1个月前
已完结
An Algorithmic Approach to Umbilical Inset during DIEP Flap Reconstruction
1个月前
已完结
Pyrotinib: First Global Approval
1个月前
已完结
Recent advances in the design of small molecular drugs with acrylamides covalent warheads
1个月前
已完结
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial
3个月前
已完结
Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
3个月前
已完结
皖公网安备34019202002308
